Suchergebnisse - "Zakrzewski, Johannes L"

PubPharm (61)

1

Author Correction : Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

enthalten in: Nature biotechnology | 2024

von Zakrzewski, J. | Suh, D. | Markley, J. | +17

ErratumFor: Nat Biotechnol. 2008 Apr;26(4):453-61. - PMID 18376399

2

Targeted Lymphoma Therapy Using a Gold Nanoframework-Based Drug Delivery System

enthalten in: ACS applied materials & interfaces | 2023

von Bariana, M. | Zhang, B. | Sun, J. | +10

3

Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation

enthalten in: Molecular cancer therapeutics | 2022

von Bariana, M. | Cassella, E. | Rateshwar, J. | +11

4

A Minimally Invasive, Accurate, and Efficient Technique for Intrathymic Injection in Mice

enthalten in: Journal of visualized experiments : JoVE | 2022

von McGuire, M. | Tuckett, A. | Myint, F. | +1

5

Author Correction : c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis

enthalten in: Nature metabolism | 2021

von Leslie, J. | Macia, M. | Luli, S. | +39

ErratumFor: Nat Metab. 2020 Nov;2(11):1350-1367. - PMID 33168981

6

c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis

enthalten in: Nature metabolism | 2020

von Leslie, J. | Macia, M. | Luli, S. | +39

ErratumIn: Nat Metab. 2021 Jan;3(1):118-119. - PMID 33303984

7

Methods for off-the-shelf tumor immunotherapy using allogeneic T-cell precursors

enthalten in: Europäisches Patentamt | 2018

von ZAKRZEWSKI JOHANNES L | VAN DEN BRINK MARCEL R M | SADELAIN MICHEL

8

Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation

enthalten in: Investigational new drugs | 2018

von Liu, H. | Tuckett, A. | Fennell, M. | +2

9

Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation

enthalten in: Investigational new drugs | 2018

von Liu, H. | Tuckett, A. | Fennell, M. | +2

10

Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation

enthalten in: Investigational new drugs | 2018

von Liu, H. | Tuckett, A. | Fennell, M. | +2

1
2
3
4
5
6
7
Nächster »
[7]